TUBA1B and glioblastoma: Further comparative analysis of TUBA1B expression levels across tumor tissues showed that glioblastoma multiforme (GBM) had the highest expression, while hepatocellular carcinoma (LIHC) exhibited the lowest (Figure 1B).